12 Most Shorted Stocks to Buy in 2026

7. Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 12 Most Shorted Stocks to Buy in 2026. On March 11, Barclays analyst Glen Santangelo lifted its price objective on the company’s stock to $29 from $25, while keeping an “Overweight” rating. The analyst highlighted that a strong increase in share price after the Novo Nordisk agreement reflects a significant market opportunity.

Additionally, it also demonstrates the removal of legal overhang for Hims & Hers Health, Inc. (NYSE:HIMS)’s stock. As per the firm, the broader market has been underappreciating the company’s opportunity from new products.

Notably, in a different release, Hims & Hers Health, Inc. (NYSE:HIMS) announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s. In the US, the company aims to offer GLP-1 customers access to a broad assortment of medications that are FDA-approved, and provide compounded semaglutide via the platform on a limited scale.

Hims & Hers Health, Inc. (NYSE:HIMS is a consumer-first health and wellness platform, connecting consumers to licensed healthcare professionals.